(Boursier.com) — The clinical-stage biopharmaceutical company, Aelis Farma, made, on February 21, an additional contribution of €200,000 in cash to the resources allocated to the liquidity contract signed on December 27, 2022 with Invest Securities. This increase aims to rebalance the resources allocated, ensure better liquidity for the security and avoid, where applicable, price shifts not justified by the market trend. After taking this contribution into account, the resources allocated to the liquidity contract were 38,616 shares and 13,755.35 euros in cash.
©2023 Boursier.com